Successful FDA inspection at Future Diagnostics
Future Diagnostics Solutions B.V. is proud to announce the successful completion of its fifth Food and Drug Administration (FDA) inspection last month. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices.
The four-day inspection was undertaken by an FDA investigator from December 9-12, 2019. The inspection confirms the total commitment to quality and teamwork of our colleagues. Our team successfully completed the audit, ensuring our commitment to accelerate healthcare innovation, providing high-quality assay development and manufacturing services.
“I would like to congratulate everyone for the teamwork and the efforts, and we thank our customers for their continued trust in us,” said Mike Klinkenberg, Managing Director of Future Diagnostics.
Future Diagnostics Solutions
Future Diagnostics offers in vitro diagnostic (IVD) immunoassay development services for start-ups, mid-sized biotech companies and multinationals in the global IVD medical device market. With 20+ years of expert experience and 150 IVD developments, our 60+ enthusiastic and highly skilled professionals are committed to accelerating healthcare innovation, providing high-quality assay development and manufacturing services.